$RKLB enters the Nasdaq-100, but tech charts show a classic "sell the news" profit-taking today. Down ~7% after hours, but long-term backing remains rock solid with a $2.2B backlog. Buy the dip?

$OCGN: Focus shifts to the upcoming rolling FDA submission for blindness gene therapy OCU400 next quarter. $DARE: Anticipation builds for this month's US commercial launch of Flora Sync LF5, generating its first-ever direct product revenue.

$VKTX Update Viking Therapeutics names Dr. Hubert Chen as new CMO to accelerate Phase 3 trials for its obesity drug VK2735.

$LPK Another interesting use case: LPKF's ProtoLaser U4 is enabling next-gen bioelectronics research in cardiac applications. Precision laser technology opening doors in MedTech, not just electronics. lpkf.com/en/news-press/lpkf-…

$LPK Positive sign: the biggest short seller appears to be reducing its position. Less short pressure strong technology catalysts (LIDE, AI, advanced packaging) could create an interesting setup.

$LPK' June event calendar remains busy: P GFAB Conference (Jun 14-17, Chicago) - showcasing Laser Transfer Printing (LTP) for the glass industry Automotive Electronics Congress (Jun 16-17, Germany) Evertiq Expo Berlin (Jun 18) 9 Depaneling Day (Jun 24, Garbsen)

$LPK up strongly as visibility continues to grow. ✔️ SDAX inclusion ✔️ ATA technology showcased at KUTENO ✔️ New research publication ✔️ Market waiting for LIDE customer announcements ad-hoc-news.de/boerse/news/u…

Mentioned $NUAI 3 days ago. 18% today. The market seems to be paying attention to the story now.

What a massive comeback for $LPK! 🚀 Dropped early on, but just wrapped up the day with an incredible ~13% surge back to €21.10 With short sellers covering and the team absolutely crushing it at 3 global expos right now, the momentum is undeniably back. Who else bought the dip?

New executives. Project financing secured. Texas AI campus under development. The next major catalyst for $NUAI is proving customer demand and execution.

Current $LPKF bear case: no production orders. Current $LPKF bull case: first production orders. That’s why every headline matters right now. Risk is high, but so is the potential upside.

June 17. Falcon 9. BlueBird 8, 9 & 10. One of the biggest catalysts of the year for $ASTS

$RKLB Everyone watches SpaceX. Few pay attention to the publicly traded companies building alongside the growth of the commercial space industry.

$ALRIB is emerging as a notable AI & silicon photonics play. Key June catalysts: • First ROSIE system delivered • ROSIE 2 production underway for 2027 rollout • June 17 AGM: vote on 25% dividend increase (€0.10/share) • June 22 ex-dividend date

Live from the JPCA Show in Tokyo $LPK is running a massive global sales offensive to showcase its breakthrough LIDE technology for the AI semiconductor market. 🇯🇵

$LPK jetzt zieht sich ein Top-Shortseller zurück: Frische Daten zeigen, dass der Hedgefonds Voleon Capital Management begonnen hat seine Netto-Short-Positionen überraschend abzubauen.

Just thought this was interesting: $LPK is an unknown SpaceX supplier. You can find it in SpaceX US import logs. It's fun information discovery ahead of Space'x IPO this week. Though, not sure what the exact contract entails. Disclosure: I have positions in LPK, NFA, credit to my follower Albert_TheVoid for the DM! Especially since everyone seems to be talking about about SpaceX with Velo... Just a fun, new direct relationship between $LPK and SpaceX if people want to do more digging.

I bought more LPK today after reading this arricle etnews.com/20260609000239

Still have my $AXTI, and positions in others I haven’t mentioned as much like $ALRIB or $LPK. Axt different reason though, one part is dilution concerns, so there’s some newer float structure risks. Other part is not wanting to cause more export controls by talking about some things

US CPI hits expectations perfectly. No market shocks, predictable path for the Fed. Investors are now switching focus back to corporate earnings. #Stocks #Inflation #Finance